SOX6 is a transcription factor belonging to the SoxD family that functions as a master regulator in multiple developmental and homeostatic processes. Primary function: SOX6 acts as a DNA-binding transcription factor that specifically recognizes the 5'-AACAAT-3' motif in enhancers and super-enhancers, regulating genes critical for chondrogenesis, oligodendrocyte development, and mesenchymal differentiation 1. Mechanism: SOX6 cooperatively binds with SOX5 and SOX9 on active regulatory elements associated with cartilage-specific genes, potentiating SOX9's transactivation capability during chondrocyte differentiation 1. In oligodendrocytes, SOX6 redistributes from super-enhancers to gene bodies during maturation, with its suppression accelerating the transition to mature, myelinating oligodendrocytes 2. Disease relevance: Dysregulation of SOX6 has been implicated in multiple pathological conditions including diabetes, cardiomyopathy, hypertension, autoimmune diseases, osteoarthritis, and cancer 34. SOX6 expression is regulated by microRNAs, and dysregulation of this interplay contributes to disease pathogenesis 3. In intestinal inflammation, SOX6+ mesenchymal cells maintain an epithelial stem cell niche that becomes dysregulated in inflammatory bowel disease 5. Clinical significance: SOX6 represents a potential therapeutic target for multiple conditions, particularly for promoting oligodendrocyte maturation in demyelinating diseases like multiple sclerosis 2.